Ginkgolide A
CAS No. 15291-75-5
Ginkgolide A( Ginkgolide A | BN 52020 | BN 52020 )
Catalog No. M18065 CAS No. 15291-75-5
Ginkgolide A is a highly active PAF antagonist cage molecule that is isolated from the leaves of the Ginkgo biloba tree. Shows potential in a wide variety of inflammatory and immunological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 30 | In Stock |
|
| 25MG | 56 | In Stock |
|
| 50MG | 88 | In Stock |
|
| 100MG | 143 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGinkgolide A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGinkgolide A is a highly active PAF antagonist cage molecule that is isolated from the leaves of the Ginkgo biloba tree. Shows potential in a wide variety of inflammatory and immunological disorders.
-
DescriptionGinkgolide A is GSK-3β inhibitor and potential PXR agonist found in Ginkgo. It decreases phosphorylation of Tau protein, prevents neointimal hyperplasia and decreases anxiety.
-
In Vitro——
-
In Vivo——
-
SynonymsGinkgolide A | BN 52020 | BN 52020
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorGABAR
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number15291-75-5
-
Formula Weight408.4
-
Molecular FormulaC20H24O9
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 244.86 mM
-
SMILESO1[C@H]2C[C@]34[C@@H]5OC(=O)[C@]3(O[C@@H]3OC(=O)[C@H](O)[C@]43[C@H](C(C)(C)C)C5)[C@@]2(O)[C@H](C)C1=O
-
Chemical Name9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta(c)furo(2,3-b)furo(3',2':3,4)cyclopenta(1,2-d)furan-5,9,12(4H)-trione, 3-(1,1-dimethylethyl)hexahydro-4,7b-dihydroxy-8-methyl-, (1R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11aS)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhao Q, Gao C, Cui Z. Int Immunopharmacol. 2015 Apr;25(2):242-8.
molnova catalog
related products
-
mulberroside B
Antitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
-
MW181 hydrochloride
MW181 (MW01-10-181SRM) is an isoform-selective, brain-permeable, and orally bioavailable small molecule inhibitor of p38α MAPK with Ki of 184 nM.
-
Darizmetinib
Darizmetinib (HRX215, HRX-0215) is an MKK4 inhibitor. Inhibition of MKK4 leads to enhancement of the MKK7 and JNK1 signaling pathways, thereby activating the transcription factors ATF2 and ELK1, promoting cell proliferation and liver regeneration.
Cart
sales@molnova.com